✦ LIBER ✦

P374 LONG-TERM TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH THE FXR AGONIST OBETICHOLIC ACID SHOWS DURABLE EFFICACY

✍ Scribed by Kowdley, K.; Hirschfield, G.; Chapman, R.; Vincent, C.; Jones, D.; Pares, A.; Luketic, V.; Gordon, S.; Pencek, R.; Marmon, T.; Hooshmand-Rad, R.

Book ID: 122329702
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 81 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60536-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

952 LONG-TERM (LT) THERAPY OF A FARNESOI

952 LONG-TERM (LT) THERAPY OF A FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) MAINTAINS BIOCHEMICAL RESPONSE IN PRIMARY BILIARY CIRRHOSIS (PBC)

✍ G. Hirschfield; K. Kowdley; A. Mason; V. Luketic; S. Gordon; C. Vincent; M. Mayo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Ursodeoxycholic acid in the treatment of

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: A short-term, randomized, double-blind controlled, cross-over study with long-term follow up

✍ S-J. HWANG; C-Y. CHAN; S-D. LEE; J-C. WU; S-H. TSAY; K-J. LO 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB